甲状腺疾病和脂代谢

宋勇峰; 王凯

doi:10.13201/j.issn.1001-1439.2022.09.002

甲状腺疾病和脂代谢

宋勇峰^1, ,,
王凯¹

- 山东第一医科大学附属省立医院内分泌科(济南，250021)

详细信息

通讯作者: 宋勇峰，E-mail：syf198506@163.com

中图分类号: R581

收稿日期: 2022-08-08

刊出日期: 2022-09-13

Thyroid disease and lipid metabolism

SONG Yongfeng^1, ,,
WANG Kai¹

- Department of Endocrinology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Ji′nan, 250021, China

More Information

Corresponding author: SONG Yongfeng, E-mail: syf198506@163.com

Received Date: 08 August 2022

Publish Date: 13 September 2022

摘要

摘要: 近年来，随着甲状腺疾病及脂代谢异常发病率上升，甲状腺疾病与脂代谢异常的研究逐渐引发关注。在临床工作中，甲状腺疾病常伴有脂代谢异常。既往研究提示甲状腺激素、促甲状腺素参与了脂代谢过程的调控，然而，脂代谢异常也可参与多种甲状腺疾病的发生发展。甲状腺疾病和脂代谢的相关性及其机制的深入研究可以为制定新的疾病诊治思路提供依据。
- 甲状腺疾病 /
- 脂代谢 /
- 促甲状腺激素
Abstract: The incidence of thyroid diseases and abnormal lipid metabolism has increased in recent years. Research on thyroid diseases and lipid metabolism has received more attention. In clinical practice, thyroid diseases are often accompanied by dyslipidemia. Previous studies have indicated that thyroid hormone and thyrotropin participate in lipid metabolism. However, abnormal lipid metabolism can also play an importance role in the occurrence and development of various thyroid diseases. Further studies on specific mechanisms underlying the association between thyroid diseases and lipid metabolism could provide new ideas for diagnosis and treatment of diseases
- thyroid disease /
- lipid metabolism /
- thyrotropin

HTML全文

参考文献(25)

[1]	Zhang M, Deng Q, Wang L, et al. Prevalence of dyslipidemia and achievement of low-density lipoprotein cholesterol targets in Chinese adults: A nationally representative survey of 163, 641 adults[J]. Int J Cardiol, 2018, 260: 196-203. doi: 10.1016/j.ijcard.2017.12.069
[2]	Taylor PN, Albrecht D, Scholz A, et al. Global epidemiology of hyperthyroidism and hypothyroidism[J]. Nat Rev Endocrinol, 2018, 14(5): 301-316. doi: 10.1038/nrendo.2018.18
[3]	Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer[J]. Thyroid, 2016, 26(1): 1-133. doi: 10.1089/thy.2015.0020
[4]	Kitahara CM, Sosa JA. The changing incidence of thyroid cancer[J]. Nat Rev Endocrinol, 2016, 12(11): 646-653. doi: 10.1038/nrendo.2016.110
[5]	杨利波. 甲状腺功能减退与血脂异常[J]. 中国实用内科杂志, 2014, 34(4): 340-343. https://www.cnki.com.cn/Article/CJFDTOTAL-SYNK201404011.htm
[6]	王欢. 甲状腺癌患者体质指数、血脂及血清瘦素水平的变化[C]// 中国营养学会第十三届全国营养科学大会暨全球华人营养科学家大会论文汇编. 2017: 507-508.
[7]	Su X, Peng H, Chen X, et al. Hyperlipidemia and hypothyroidism[J]. Clin Chim Acta, 2022, 527: 61-70. doi: 10.1016/j.cca.2022.01.006
[8]	邱堃. 甲亢患者的甲状腺激素水平与血脂水平联系的临床研究进展[J]. 河北医学, 2015.21(9): 1531-1533. doi: 10.3969/j.issn.1006-6233.2015.09.042
[9]	肖创清. 甲状腺功能异常与血脂水平的相关性研究[J]. 中国普通外科杂志, 2015, 24(6): 861-864. https://www.cnki.com.cn/Article/CJFDTOTAL-ZPWZ201506025.htm
[10]	Duntas LH. Thyroid disease and lipids[J]. Thyroid, 2002, 12(4): 287-293. doi: 10.1089/10507250252949405
[11]	Sinha RA, Singh BK, Yen PM. Direct effects of thyroid hormones on hepatic lipid metabolism[J]. Nat Rev Endocrinol, 2018, 14(5): 259-269. doi: 10.1038/nrendo.2018.10
[12]	Mullur R, Liu YY, Brent GA. Thyroid hormone regulation of metabolism[J]. Physiol Rev, 2014, 94(2): 355-382. doi: 10.1152/physrev.00030.2013
[13]	魏立民. 甲状腺激素对肝脂代谢调节及相关非经典通路的研究进展[J]. 医学综述, 2015, 21(20): 3680-3683. doi: 10.3969/j.issn.1006-2084.2015.20.013
[14]	de Lange P. Rapid activation by 3, 5, 3'-L-triiodothyronine of adenosine 5'-monophosphate-activated protein kinase/acetyl-coenzyme a carboxylase and akt/protein kinase B signaling pathways: relation to changes in fuel metabolism and myosin heavy-chain protein content in rat gastrocnemius muscle in vivo[J]. Endocrinology, 2008, 149(12): 6462-6470. doi: 10.1210/en.2008-0202
[15]	Garduño-Garcia Jde J, Alvirde-Garcia U, López-Carrasco G, et al. TSH and free thyroxine concentrations are associated with differing metabolic markers in euthyroid subjects[J]. Eur J Endocrinol, 2010, 163(2): 273-278. doi: 10.1530/EJE-10-0312
[16]	促甲状腺激素对脂代谢的调控及机制. 山东省, 山东省立医院, 2013-02-24.
[17]	Yang H. Association of adiposity with thyroid nodules: a cross-sectional study of a healthy population in Beijing, China[J]. BMC endocrine disorders, 2019, 19(1): 102. doi: 10.1186/s12902-019-0430-z
[18]	王晓艳, 王亚军, 蒿花, 等. 甲状腺结节与代谢综合征相关组分的临床研究[J]. 西安交通大学学报(医学版), 2017, 38(1): 151-153. https://www.cnki.com.cn/Article/CJFDTOTAL-XAYX201701036.htm
[19]	刘瑶. 甲状腺结节与代谢紊乱研究进展[J]. 临床医药实践, 2016, 25(6): 450-452. https://www.cnki.com.cn/Article/CJFDTOTAL-SXLC201606017.htm
[20]	Kim HK. Higher TSH level is a risk factor for differentiated thyroid cancer[J]. Clin Endocrinol(Oxf), 2013, 78(3): 472-477. doi: 10.1111/cen.12027
[21]	Kim J. Repeated low high-density lipoprotein cholesterol and the risk of thyroid cancer: a nationwide population-based study in Korea[J]. Endocrinol Metab(Seoul), 2022, 37(2): 303-311. doi: 10.3803/EnM.2021.1332
[22]	Revilla G, Pons MP, Baila-Rueda L, et al. Cholesterol and 27-hydroxycholesterol promote thyroid carcinoma aggressiveness[J]. Sci Rep, 2019, 9(1): 10260. doi: 10.1038/s41598-019-46727-2
[23]	Yin DT. The association between thyroid cancer and insulin resistance, metabolic syndrome and its components: A systematic review and meta-analysis[J]. Int J Surg, 2018, 57: 66-75. doi: 10.1016/j.ijsu.2018.07.013
[24]	Park JH. Metabolic syndrome and the risk of thyroid cancer: a nationwide population-based cohort study[J]. Thyroid, 2020, 30(10): 1496-1504. doi: 10.1089/thy.2019.0699
[25]	孙羽. 甲亢患者的甲状腺激素水平与血脂水平联系的临床研究进展[J]. 河北医学, 2015, 21(9): 1531-533. doi: 10.3969/j.issn.1006-6233.2015.09.042